v3.0.7
Please consider this website is continuously evolving and still under development
to harmonize automatic data extraction and integrate manual data annotation.
Column | Value |
---|---|
Trial registration number | NCT04762628 |
Full text link
Last imported at : Feb. 23, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
|
First author
Last imported at : Feb. 23, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
|
Contact
Last imported at : Feb. 23, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
Not reported |
Registration date
Last imported at : Feb. 24, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
2021-02-21 |
Recruitment status
Last imported at : Aug. 10, 2021, 3:30 p.m. Source : ClinicalTrials.gov |
Completed |
Study design
Last imported at : Feb. 23, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
RCT |
Allocation
Last imported at : Feb. 23, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
Randomized |
Design
Last imported at : Feb. 23, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
Adaptive |
Masking
Last imported at : Feb. 23, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
Open label |
Center
Last imported at : March 15, 2023, 4 a.m. Source : ClinicalTrials.gov |
multi-center |
Study aim
Last imported at : Feb. 23, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
Treatment |
Inclusion criteria
Last imported at : March 1, 2023, 9:56 a.m. Source : ClinicalTrials.gov |
inclusion criteria: patients found to have positive rt-pcr for sars-cov-2 in any specimen on 4 days prior to randomization, those who are hospitalized with evidence of respiratory disease during clinical assessment or imaging male or non-pregnant female adult ≥18 years of age subject (or legally authorized representative) provides informed consent prior to initiation of any study procedures subject (or legally authorized representative) understands and agrees to comply with planned study procedures has illness of not more than 7 days duration at the time of enrolment does not require immediate resuscitation or mechanical ventilation respiration rate ≤ 29 per minute spo2 ≤ 95% on room air agrees to not participate in another clinical trial through day 29 |
Exclusion criteria
Last imported at : March 1, 2023, 9:56 a.m. Source : ClinicalTrials.gov |
pregnant or breastfeeding women known allergy to dairy products on corticosteroids for covid-19 therapy at the time of screening subjects who are taking corticosteroids or other immunosuppressive drugs for other medical conditions concurrent malignancy requiring chemotherapy known renal insufficiency with glomerular filtration rate (egfr) < 30 ml/min (including patients receiving hemodialysis or hemofiltration). alt or ast > 5 times the upper limit of normal subjects receiving other immune-based therapy for covid-19, such as convalescent plasma, immunoglobulin products, interferons |
Number of arms
Last imported at : Feb. 23, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
3 |
Funding
Last imported at : Feb. 23, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
Saisei Pharma |
Inclusion age min
Last imported at : Feb. 23, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
18 |
Inclusion age max
Last imported at : Feb. 23, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
100 |
Countries
Last imported at : Feb. 23, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
Ukraine |
Type of patients
Last imported at : Feb. 23, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
Moderate/severe disease at enrollment |
Severity scale
Last imported at : Feb. 23, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
4: Moderate/severe disease at enrollment |
Total sample size
Last imported at : Feb. 23, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
600 |
primary outcome
Last imported at : Feb. 23, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
14-day Participant Mortality;29-day Participant Mortality;The time to basic clinical improvement and to recovery defined as the following |
Notes
Last imported at : Feb. 23, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
None |
Phase
Last imported at : Nov. 16, 2021, 6:30 p.m. Source : ClinicalTrials.gov |
Not reported |
Arms
Last imported at : Feb. 23, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
[{"arm_notes": "", "treatment_id": 764, "treatment_name": "Maf capsules", "treatment_type": "Nutrition", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "", "treatment_id": 772, "treatment_name": "M capsules", "treatment_type": "Nutrition", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}] |